Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences
Vanda Pharmaceuticals schedules multiple September 2026 healthcare investor conference appearances, with select presentations available via live and archived webcasts.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Vanda Pharmaceuticals (VNDA) will participate in four investor conferences in September 2026, including events hosted by Wells Fargo, Cantor, H.C. Wainwright and Morgan Stanley.
Corporate presentations at the Cantor and H.C. Wainwright conferences will be webcast live and archived for about 30 days on Vanda's website.
Details
News Market Reaction – VNDA
On Sep 3, the first trading day after this news, VNDA closed 3.44% below the previous close.
Data tracked by StockTitan Argus for the Sep 3 session.
Key Figures
- Wells Fargo conference date
- September 8, 2026
- 21st Annual Healthcare Conference
- Cantor conference date
- September 11, 2026
- 2026 Global Healthcare Conference
- Cantor presentation time
- 8 a.m. Eastern Time
- 2026 Global Healthcare Conference
- H.C. Wainwright conference date
- September 15, 2026
- 28th Annual Global Investment Conference
- H.C. Wainwright presentation time
- 10 a.m. Eastern Time
- 28th Annual Global Investment Conference
- Morgan Stanley conference date
- September 16, 2026
- 24th Annual Global Healthcare Conference
- Archive availability
- approximately 30 days
- Archived conference availability on Vanda's website
Historical Context
-
European Commission granted orphan designation for imsidolimab in generalized pustular psoriasis.
-
Sales declined year over year while quarterly losses widened despite reiterated revenue guidance.
-
Vanda scheduled its second-quarter financial-results release and conference call for August 5.
-
EMA committee issued a positive opinion recommending orphan designation for imsidolimab.
-
NEREUS sponsorship partnership was announced with the No. 47 IndyCar entry.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The Wells Fargo 21st Annual Healthcare Conference in
The 2026 Cantor Global Healthcare Conference in
The H.C. Wainwright 28th Annual Global Investment Conference in
The Morgan Stanley 24th Annual Global Healthcare Conference in
The corporate presentations given at the 2026 Cantor Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-september-2026-investor-conferences-302868188.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.